Search All News
Columbia researchers have uncovered an array of new genes that cause stillbirth, significantly increasing the understanding of the genetic foundations of a common, but little studied, condition.
New genetic and patient analyses suggest severe COVID is linked to overactive complement, one of the immune system’s oldest branches, and excess blood clotting.
- June 19, 2019
Four physician-scientists at the Vagelos College of Physicians and Surgeons have been named 2019 Louis V. Gerstner Jr. Scholars, and a fifth has been named a 2019 Louis V. Gerstner Jr. Merit Awardee.
- June 12, 2019
Scientists at Columbia have developed a gene-editing tool—using jumping genes—that inserts any DNA sequence into the genome without cutting, fixing a major shortcoming of existing CRISPR technology.
- May 22, 2019
A new study of a single-celled organism with 16,000 tiny chromosomes may shed light on a recently discovered feature of the human genome.
- May 15, 2019
A study shows that one in 7 kidney donor-recipient pairs may have a type of genetic incompatibility that leads to organ rejection.
- May 14, 2019
A new study suggests that providers make the same number of wrong-patient errors regardless of the number of electronic patient records they could have open at a time.
- May 10, 2019
Columbia engineers and surgeons show that new salvage methods can recondition severely damaged lungs to meet transplantation criteria and could make more lungs available for patients.
- May 7, 2019
A new study suggests that depression and GI trouble sometimes spring from the same source—low serotonin—and identifies a potential treatment that could ease both conditions.
- May 2, 2019
Four researchers at VP&S have been named 2019 Schaefer Research Scholars and will pursue new ideas in cancer metastasis, neurodegenerative disease, and compulsive behavior.
- April 9, 2019
A new study from Columbia pediatricians found that new mothers are more receptive to educational materials that contain facts, not criticism, about sugary drinks.
- April 1, 2019
Columbia researchers may have uncovered a new way to prevent, and possibly reverse, the liver's deterioration during fatty liver disease, which affects one in four Americans.